Brain imaging study of LG-0317 in healthy men
This study tests a single dose of LG-0317 tablets to see how much of the brain's serotonin transporter it occupies. It uses PET/CT scans and is for healthy men only. Results will help understand how the drug works in the brain.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are a healthy man between 18 and 45 years old.
- You weigh at least 110 pounds (50 kg) and have a body mass index (BMI) between 19 and 28.
- You have no major medical conditions, including neurological, psychiatric, or heart problems.
- You do not smoke more than 5 cigarettes a day and drink less than 21 alcoholic drinks per week.
- You have not taken any prescription or over-the-counter drugs, supplements, or herbal remedies in the past 2 weeks.
- You are willing to avoid caffeine, alcohol, and certain foods for 2 days before the study dose.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This early-stage study tests a new experimental drug called LG-0317 in healthy volunteers to see if it is safe and how the body processes it. If you are healthy and meet the basic requirements, this trial may help advance a new treatment option.
This study tests an investigational drug called LBT-3627 to see if it is safe and how the body processes it. It includes healthy volunteers and people with Parkinson's disease, and may help determine if the drug could be a future treatment.
This study tests an investigational drug called GSM-779690T in healthy adults. It aims to understand how the drug works in the body and check for any side effects.
This Phase 1 study tests how a serotonin-related drug changes brain activity in healthy adults, using brain imaging (MRI) and other measures. Because it involves a drug that may affect the brain, eligibility is designed to keep the results safe and clear.
This trial tests an investigational drug in healthy people to see how safe it is and how the body processes it. It may help researchers decide if the drug should be studied further for a specific condition.
This study tests how a new drug, ITI-1284, works in the brain using PET scans. It helps researchers understand how the drug binds to receptors and how safe it is in healthy people.
Hear when a new Healthy Volunteers (HV) trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.